New Insights into Treating Early and Advanced Stage Diabetic Retinopathy.
Ontology highlight
ABSTRACT: Diabetic retinopathy (DR) is the leading cause of preventable blindness in the working-age population. The disease progresses slowly, and we can roughly differentiate two stages: early-stage (ESDR), in which there are mild retinal lesions and visual acuity is generally preserved, and advanced-stage (ASDR), in which the structural lesions are significant and visual acuity is compromised. At present, there are no specific treatments for ESDR and the current recommended action is to optimize metabolic control and maintain close control of blood pressure. However, in the coming years, it is foreseeable that therapeutic strategies based in neuroprotection will be introduced in the clinical arena. This means that screening aimed at identifying patients in whom neuroprotective treatment might be
SUBMITTER: Simo R
PROVIDER: S-EPMC9368971 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA